BASIC AND CLINICAL BIOLOGY OF CUTANEOUS T CELL LYMPHOMA

皮肤 T 细胞淋巴瘤的基础和临床生物学

• 批准号: 6031934
• 负责人: RICHARD Leslie EDELSON
• 金额: $ 1万
• 依托单位: NEW YORK ACADEMY OF SCIENCES
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-05-01 至 2001-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6031934
• 关键词: meeting /conference /symposium; mycosis fungoides lymphoma; travel

DESCRIPTION (Applicant's Description) The New York Academy of Sciences is sponsoring a conference entitled: Basic and Clinically Relevant Biology of Cutaneous T Cell Lymphoma in late Spring, 2000. The principal investigator and chair is Richard L. Edelson, M.D., Professor and Chairman Department of Dermatology, Yale University School of Medicine. The cochair is Vincent DeVita, M.D., Professor of Medicine and Director of the Comprehensive Cancer Center, Yale University School of Medicine. The purpose of this conference is to broaden the scientific exchanges between leading immunologists, hemato-oncologists, experimental pathologists and investigative dermatologists on the subject of Cutaneous T Cell Lymphoma, to bring this disease more into the cancer mainstream and to highlight the significant advances in its understanding that have been made in recent years. Cutaneous T cell lymphoma (CTCL) receives much attention from the scientific and clinical communities, since it is a relatively common and dangerous malignancy, which serves as a testing ground for a wide range of immunotherapies. However, since Dr. Edelson's team first identified the disease in 1975 and conducted an NIH Clinical Staff Conference on the subject, later published in the Annals of Internal Medicine, there has been a paucity of comprehensive conferences effectively placing knowledge of the biology of CTCL in the broader context of research in other lymphomas. This has led to an unfortunate compartmentalization, and even isolation, of expertise in the disorder: a large subset of dermatologists, with only a sprinkling of oncologists and pathologists, have worked on the subject. We hope to catalyze direct communication on the important subject between immunologists, who investigate this most common adult malignancy of T lymphocytes, dermatologists, who care for the often seriously ill patients, and research oncologists and experimental pathologists, whose expertise could help move knowledge of clinically relevant CTCL biology forward, even faster. The proceedings will be published as a volume in the Annals of the New York Academy of Sciences and will be distributed internationally.

纽约科学院是 主办一个会议，题为：基础和临床相关的生物学， 2000年春末皮肤T细胞淋巴瘤。主要研究者和 主持人：Richard L. Edelson，医学博士，教授兼系主任 耶鲁大学医学院皮肤科。联合主席是文森特 德维塔，医学博士，医学教授和综合癌症主任 中心，耶鲁大学医学院。 这次会议的目的是扩大科学交流之间的 领先的免疫学家，血液肿瘤学家，实验病理学家和 调查皮肤科医生对皮肤T细胞淋巴瘤的主题， 将这种疾病更多地纳入癌症主流， 近年来，对这一问题的认识取得了重大进展， 年 皮肤T细胞淋巴瘤（CTCL）受到科学界的广泛关注。 和临床社区，因为它是一个相对常见和危险的 一个人，是一个人。 免疫疗法 然而，自从埃德尔森博士的团队首次发现了 疾病在1975年，并进行了一个国家卫生研究院临床工作人员会议上的主题， 后来发表在《内科学年鉴》上， 全面的会议有效地将生物学的知识， CTCL在其他淋巴瘤研究的更广泛背景下。这导致 不幸的是，专业知识的划分，甚至孤立， 疾病：皮肤科医生的一个大的子集，只有零星的 肿瘤学家和病理学家一直在研究这个问题。 我们希望能催化 免疫学家之间就重要问题进行直接交流， 研究这种最常见成人T淋巴细胞恶性肿瘤， 皮肤科医生，谁照顾往往重病患者，和研究 肿瘤学家和实验病理学家，他们的专业知识可以帮助移动 临床相关CTCL生物学知识的发展甚至更快。 会议记录将作为一卷在《纽约年鉴》上出版。 科学院，并将在国际上分发。